9(1)05
Nauka innov. 2013, 9(1):44-54
https://doi.org/10.15407/scin9.01.044
D.F. Gluzman1, L.M. Sklyarenko1, V.A. Nadgornaya1, M.P. Zavelevich1, L.Yu. Poludnenko1, T.S. Ivanovskaya1, N.I. Ukrainskaya1, G.D. Тelegeev2, M.V. Dybkov2, L.A. Polischuk2
1 R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv
2 Institute of Molecular Biology and Genetics, NAS of Ukraine, Kyiv
Development of Complex of Immunocytochemical and Molecular Genetic Technologies for Acute Leukemia Diagnostics and their Implementation into Clinical Practice
Section: Scientific and Technical Innovative Projects of National Academy of Sciences of Ukraine
Language: Ukrainian
Abstract: The state-of-the-art technologies of diagnosing acute leukemias (AL) based on the novel WHO classification have been developed. The major forms and cytological variants of hematoblastoses have been diagnosed precisely in 755 patients in Ukraine with one third of them suffering from AL. The primers for detecting the transcripts of chimerical genes bcr/abl (t(9;22)(q34;q11)); mll/af4 (t(4;11) (q21;q23)); mll/af9 (t(9;11)(p22;q23)) in reverse transcriptase polymerase chain reaction (RT-PCR) have been designed. RT-PCR has been used for differential diagnostics in AL patients.
Key words: acute leukemias, cytomorphological diagnostics, immunophenotyping, reverse transcriptase polymerase chain reaction.
References:
1. Bennett J.M., Catovsky D., Daniel M.T. et al. FrenchAmerican-British (FAB) Cooperative Group: proposals for the classification of the acute leukemias. Br. J. Haematol. 1976. V. 33. 451 p.
2. Swerdlow S.H., Campo E., Harris N.L. et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press. 2008. 439 p.
3. Jaffe E.S., Harris N.L., Stein H., Vardiman Y.W. Pathology and genetics of haematopoietic and lymphoid tissues. Lyon: IARC Press. 2001. 351 p.
4. Löffler H., Rastetter J. Atlas of clinical hematology. 6th ed. Berlin, Heidelberg: Springer-Verlag. 2005. 429 p.
5. Bain B.J., Matutes E. Myeloid malignancies: an atlas of investigation and diagnosis. London: Clinical Publishing, 2010. 144 p.
6. Bennett J.M., Catovsky D., Daniel M.-T. et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Intern. Med. 1985. V. 103. 626 p.
7. Bain B.J. Leukemia diagnosis. 4th ed. London: WileyBlackwell. 2010. 377 p.
https://doi.org/10.1002/9781444318470
8. Gluzman D.F., Skljarenko L.M., Nadgornaja V.A. Opuholi krovetvornoj i limfoidnoj tkanej (citomorfologija, immunocitohimija, algoritmy diagnostiki). Kyiv: Izd. DIA, 2008. 196 s. [in Russian].
9. Gluzman D.F., Nadgornaja V.A., Skljarenko L.M i dr. Novaja klassifikacija opuholej limfoidnoj tkani (VOZ, 2008). Serija Seminari z gematopatologii. Vip. 20. Kyiv: Izd. DIA, 2009. 36 s. [in Russian].
10. Gluzman D.F., Sklyarenko L.M., Nadgornaya V.A. et al. Immunocytochemical markers in acute leukaemias dia g nosis. Experim. Oncol. 2010. V. 32, No. 3. P. 195-199.
11. Diagnostychna onkogematologija. Pid red. D.F. Gluzmana. Kyiv: Vyd. DIA, 2011. 256 s. [in Ukrainian].
12. Bueno C., Montes R., Catalina P. et al. Insights into the cellular origin and etiology of the infant pro-B acute lympho blastic leukemia with MLL-AF4 rearrangement. Leukemia. 2011. V. 25, No. 3. P. 400-410.
https://doi.org/10.1038/leu.2010.284
13. Telegeev G.D., Dubrovska A.N., Nadgornaya V.A., Gluzman D.F. Immunocytochemical study of BCR and BCRABL localization in K-562 cells. Experim. Oncol. 2010. V. 32, No. 2. P. 81-83.
14. Langer T., Metzler M., Reinhardt D. et al. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides. Genes Chromosomes Cancer. 2003. V. 36, N. 4. P. 393-401.
https://doi.org/10.1002/gcc.10167
15. Dawson A.J., Bal S., McTavish B. et al. Inversion and deletion of 16q22 defined by array CGH, FISH, and RTPCR in a patient with AML. Cancer Genet. 2011. V. 204, No. 6. P. 344-347.
https://doi.org/10.1016/j.cancergen.2011.05.005